Study calls for AF (atrial fibrillation) ablation in HF patients with CRT HF (heart failure) patients who have a CRT device
This article was originally published in Clinica
Executive Summary
An Italian study has backed the use of ablation to treat permanent atrial fibrillation (AF) in patients who also suffer from heart failure (HF) and have received an implantable cardiac resynchronisation therapy (CRT) device.
You may also be interested in...
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.